Cell migration-The role of integrin glycosylation

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 6, 2010, Pages 545-555

  Janik, Marcelina E ^a   Lityńska, Anna ^a   Vereecken, Pierre ^b,c,d,e  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d JULES BORDET INSTITUTE   (Belgium)

^e Institut Bordet   (Belgium)

Author keywords

3 1 integrin; 5 1 integrin; v 3 integrin; Migration; N oligosaccharides

Indexed keywords

ACTIN; ALPHA INTEGRIN; BETA INTEGRIN; DIMER; INTEGRIN; INTEGRIN RECEPTOR; KALININ; OLIGOSACCHARIDE; SIALIC ACID; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CYTOSKELETON; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; LIGAND BINDING; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL MOVEMENT; GLYCOSYLATION; INTEGRINS; PROTEINS;

EID: 77952287201     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.03.013     Document Type: Review

References (157)

1. Steffensen Proteolytic B. events of wound-healing coordinated interaction among Matrix Metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit. Rev. Oral Biol. Med. 2001, 12:373-398.
2. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 1996, 84:359-369.
3. Bogenrieder T., Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003, 22:6524-6536.
4. Kedrin D., van Rheenen J., Hernandez L., Condeelis J., Segall J.E. Motility and cytoskeletal regulation in invasion and metastasis. J. Mammary Gland Biol. Neoplasia 2007, 12:143-152.
5. Agiostratidou G., Hulit J., Phillips G.R., Hazan R.B. Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression. J. Mammary Gland Biol. Neoplasia 2007, 12:127-133.
6. Arnaout M.A., Goodman S.L., Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 2007, 19:495-507.
7. Staff A.C. An introduction to cell migration and invasion. Scan. J. Clin. Lab. Investig. 2001, 61:257-268.
8. Yamaguchi H., Wyckoff J., Condeelis J. Cell migration in tumors. Curr. Opin. Cell Biol. 2005, 17:559-564.
9. Hotary K., Li X.-Y., Allen E., Stevens S.L., Weiss1 S.J. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 2006, 20:2673-2686.
10. Brakebusch C., Bouvard D., Stanchi F., Sakai T., Fässler R. Integrins in invasive growth. J. Clin. Invest. 2002, 109:999-1006.
11. Sahai E. Illuminating the metastatic process. Nat. Rev. Cancer 2007, 7:737-749.
12. Grande-Garcia A., del Pozo M.A. Caveolin-1 in cell polarization and directional migration. Eur. J. Cell Biol. 2008, 87:641-647.
13. Horwitz A.R., Parsons J.T. Cell migration - movin' on. Science 1999, 286:1102-1103.
14. Lock J.G., Wehrle-Haller B., Strömblad S. Cell-matrix adhesion complexes: master control machinery of cell migration. Semin. Cancer Biol. 2008, 18:65-76.
15. Mayer C., Maaser K., Daryab N., Zänker K.S., Bröcker E.-B., Friedl P. Release of cell fragments by invading melanoma cells. Eur. J. Cell Biol. 2004, 83:709-715.
16. Liddington R.C., Bankston L.A. The structural basis of dynamic cell adhesion: heads, tails, and allostery. Exp. Cell Res. 2000, 261:37-43.
17. Hynes R.O. Integrin: bidirectional allosteric signalling machines. Cell 2002, 110:673-687.
18. Schwartz M.A., DeSimon D.W. Cell adhesion receptors in mechanotransduction. Curr. Opin. Cell Biol. 2008, 20:551-556.
19. Meighan C.M., Schwarzbauer J.E. Temporal and spatial regulation of integrins during development. Curr. Opin. Cell Biol. 2008, 20:520-524.
20. Mizejewski G.J. Role of integrins in cancer: survey of expression patterns. P. S. E. B. M. 1999, 222:124-138.
21. Jin H., Varner J. Integrins: roles in cancer development and as treatment targets. Br. J. Cancer 2004, 90:561-565.
22. White D.E., Muller W.J. Multifaceted roles of integrins in breast cancer metastasis. J. Mammary Gland Biol. Neoplasia 2007, 12:135-142.
23. 3. Science 2001, 294:339-345.
24. Gahmberg C.G., Fagerholm S.C., Nurmi S.M., Chavakis T., Marchesan S., Grönholm M. Regulation of integrin activity and signalling. Biochim. Biophys. Acta 2009, 1790:431-444.
25. v integrin antagonists as novel anticancer agents: an update. Expert Opin. Investig. Drugs 2002, 11:1765-1774.
26. 1 integrin for its biological functions. Biol. Pharm. Bull. 2009, 32:780-785.
27. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 2000, 28:311-339.
28. van der Flier A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001, 305:285-298.
29. Plow E.F., Haas T.A., Zhang L., Loftusi J., Smith J.W. Ligand binding to integrins. J. Biol. Chem. 2000, 275:21785-21788.
30. Dickeson S.K., Santoro S.A. Ligand recognition by the I domain-containing integrins. Cell. Mol. Life Sci. 1998, 54:556-566.
31. Takagi J., Petre B.M., Walz T., Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002, 110:599-611.
32. Takagi J. Structural basis for ligand recognition by integrins. Curr. Opin. Cell Biol. 2007, 19:557-564.
33. Schneider D., Engelman D.M. Involvement of transmembrane domain interactions in signal transduction by α /β integrins. J. Biol. Chem. 2004, 279:9840-9846.
34. Sastry S.K., Burridge K. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp. Cell Res. 2000, 261:25-36.
35. Berman A.E., Kozlova N.I., Morozevich G.E. Integrins: structure and signaling. Biochemistry (Moscow) 2003, 68:1284-1299.
36. Mierke C.T., Rösel D., Fabry B., Brábek J. Contractile forces in tumor cell migration. Eur. J. Cell Biol. 2008, 87:669-676.
37. Wozniak M.A., Modzelewska K., Kwong L., Keely P.J. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta 2004, 1692:103-119.
38. Hehlgans S., Haase M., Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 2007, 1775:163-180.
39. van Nimwegen M.J., van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem. Pharmacol. 2007, 73:597-609.
40. Zachary I. Focal adhesion kinase. Int. J. Biochem. Cell Biol. 1997, 29:929-934.
41. Schlaepfer D.D., Mitra S.K., Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta 2004, 1692:77-102.
42. Kuphal S., Bauer R., Bosserhoff A.-K. Integrin signaling in malignant melanoma. Cancer Metastasis Rev. 2005, 24:195-222.
43. Brakebusch C., Fässler R. The integrin-actin connection, an eternal love affair. EMBO J. 2003, 22:2324-2333.
44. 1 regulates adhesion, migration and proliferation of Human Intestinal Crypt Cells via a predominant RhoA/ROCK dependent mechanism. Biol. Cell. 2009, 101:695-708.
45. Fernandez-Sauze S., Grall D., Cseh B., Van Obberghen-Schilling E. Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases. Exp. Cell Res. 2009, 315:2092-2104.
46. 4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer. J. Exp. Clin. Cancer Res. 2009, 26(28):67. 10.1186/1756-9966-28-67.
47. Keely P.J., Rusyn E.V., Cox A.D., Parise L.V. R-Ras signals through specific integrin a cytoplasmic domains to promote migration and invasion of breast epithelial cells. J. Cell Biol. 1999, 145:1077-1088.
48. Cairns R.A., Khokha R., Hill R.P. Molecular mechanisms of tumour invasion and metastasis: an integrated view. Curr. Mol. Med. 2003, 3:659-671.
49. Palecek S.P., Huttenlocher A., Horwitz A.F., Lauffenburger D.A. Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J. Cell Sci. 1998, 111:929-940.
50. Palecek S.P., Horwitz A.F., Lauffenburger D.A. Kinetic model for integrin-mediated adhesion release during cell migration. Ann. Biomed. Eng. 1999, 27:219-235.
51. Kim M., Carman C.V., Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003, 301:1720-1725.
52. Ginsberg M.H., Partridge A., Shattil S.J. Integrin regulation. Curr. Opin. Cell Biol. 2005, 17:509-516.
53. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
54. Holly S.P., Larson M.K., Parise L.V. Multiple roles of integrins in cell motility. Exp. Cell Res. 2000, 261:69-74.
55. Caswell P.T., Norman J.C. Integrin trafficking and the control of cell migration. Traffic 2006, 7:14-21.
56. 3 integrins. Anticancer Res. 2009, 29:131-138.
57. Calderwood D.A. Integrin activation. J. Cell Sci. 2004, 117:657-666.
58. Eble J.A., Haier J. Integrins in cancer treatment. Curr. Cancer Drug Targets 2006, 6:89-105.
59. Apweiler R., Hermjakob H., Sharon N. On the frequency of protein glycosylation deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473:4-8.
60. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharide. Biochem. Cell Biol. 1986, 64:163-181.
61. Kukuruzinska M.A., Lennon K. Protein N-glycosylation: molecular genetics and functional significance. Crit. Rev. Oral Biol. Med. 1998, 9:415-448.
62. Kawano S., Hashimoto K., Miyama T., Goto S., Kanehisa M. Prediction of glycan structures from gene expression data based on glycosyltransferase reactions. Bioinformatics 2005, 21:3976-3982.
63. van den Steen P., Rudd P.M., Dwek R.A., Opdenakker G. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 1998, 33:151-208.
64. Dennis J.W., Granovsky M., Warren C.E. Review: glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1999, 1473:21-34.
65. Fukuda M., Hindsqaul O. Molecular glycobiology 1994, Oxford University Press, New York.
66. Bironaite D., Nesland J.M., Risberg B., Bryne M. N-glycans influence the in vitro adhesive and invasive behavior of the three metastatic cell lines. Tumor Biol. 2000, 21:165-175.
67. Yamamoto H., Swoger J., Greene S., Saito T., Hurh J., Sweeley C., Leestma J., Mkrdichian E., Cerullo L., Nishikawa A., Ihara Y., Taniguchi N., Moskal J.R. β1, 6-N-Acetylglucosamine-bearing N-Glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res. 2000, 60:134-142.
68. Kobata A., Amano J. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol. Cell Biol. 2005, 83:429-439.
69. Taniguchi N., Miyoshi E., Jianguo G., Honke K., Matsumoto A. Decoding sugar functions by identifying target glycoproteins. Curr. Opin. Struct. Biol. 2006, 16:561-566.
70. Zhao Y., Sato Y., Isaji T., Fukuda T., Matsumoto A., Miyoshi E., Gu J., Taniguchi N. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 2008, 275:1939-1948.
71. Zhao Y.Y., Takahashi M., Gu J.G., Miyoshi E., Matsumoto A., Kitazume S., Taniguchi N. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 2008, 99:1304-1310.
72. Schauer R., Soerge K., Reuter G., Roggentin P., Shaw L. Biochemistry and role of sialic acids. Biology of the sialic acids 1995, 7-49. Plenum, New York. A. Rosenberg (Ed.).
73. Semel A.C., Seales E.C., Singhal A., Eklund E.A., Colley K.J., Bellis S.L. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J. Biol. Chem. 2002, 277:32830-32836.
74. 1 integrins. Biochim. Biophys. Acta 2004, 1663:52-60.
75. Bosques C.J., Tschampel S.M., Woods R.J., Imperiali B. Effects of glycosylation on peptide conformation: a synergistic experimental and computational study. J. Am. Chem. Soc. 2004, 126:8421-8425.
76. 1 heterodimerization, expression on the cell surface and its biological function. J. Biol. Chem. 2006, 281:33258-33267.
77. 1. J. Biol. Chem. 2009, 284:12207-12216.
78. Sato Y., Isaji T., Tajiri M., Yoshida-Yamamoto S., Yoshinaka T., Somehara T., Fukuda T., Wada Y., Gu J. An N-glycosylation site on the β-propeller domain of the integrin α5 subunit plays key roles in both its function and site-specific modification by β1, 4-N-acetylglucosaminyltransferase III. J. Biol. Chem. 2009, 284:11873-11881.
79. Takahashi M., Kuroki Y., Ohtsubo K., Taniguchi N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr. Res. 2009, 344:1387-1390.
80. Ono M., Hakomori S. Glycosylation defining cancer cell motility and invasiveness. Glycoconj. J. 2004, 20:71-78.
81. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
82. Casey R.C., Oegema T.R., Skubitz K.M., Pambuccian S.E., Grindle S.M., Skubitz A.P.N. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin. Exp. Metastasis 2003, 20:143-152.
83. Luo B.-H., Springer T.A., Takagi J. Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. PNAS 2003, 100:2403-2408.
84. 2 integrins by conversion from bent to extended conformations. Immunity 2006, 25:583-594.
85. Hakomori S. Glycosylation defining cancer malignancy. New wine in an old bottle. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:10231-10233.
86. Couldrey C., Green J.E. Metastases: the glycan connection. Breast Cancer Res. 2000, 2:321-323.
87. Gorelik E., Galili U., Raz A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 2001, 20:245-277.
88. Lau K.S., Dennis J.W. N-glycans in cancer progression. Glycobiology 2008, 18:750-760.
89. Dall'Olio F. The sialyl-α2, 6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj. J. 2000, 17:669-676.
90. Wang P.H. Altered glycosylation in cancer: sialic acids and sialyltransferases. J. Cancer Mol. 2005, 1:73-81.
91. 1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005, 65:4546-4552.
92. Christie D.R., Shaikh F.M., Lucas J.A., Lucas J.A., Bellis S.L. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J. Ovarian Res. 2008, 1:3. 10.1186/1757-2215-1-3.
93. Reddy B.V.V.G., Kalraiya R.D. Sialilated β1, 6 branched N-oligosaccharides modulate adhesion, chemotaxis and motility of melanoma cells: Effect on invasion and spontaneous metastasis properties. Biochim. Biophys. Acta 2006, 1760:1393-1402.
94. 1 integrin clustering and stimulates migration. Cancer Res. 2002, 62:6837-6845.
95. Krishnan V., Bane S.M., Kawle P.D., Naresh K.N., Kalraiya R.D. Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin. Exp. Metastasis 2005, 22:11-24.
96. Guo H.B., Liu F., Chen H.L. Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N-acetylglucosaminyltransferase V cDNA. Biochem. Biophys. Res. Commun. 1999, 264:509-517.
97. Siddiqui S.F., Pawelek J., Handerson T., Lin C.Y., Dickson R.B., Rimm D.L., Camp R.L. Coexpression of β1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome. Cancer Epidemiol. Biomark. Prev. 2005, 14:2517-2523.
98. Guo H.B., Randolph M., Pierce M. Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase. J. Biol. Chem. 2007, 282:22150-22162.
99. Wang L., Liang Y., Li Z., Cai X., Zhang W., Wu G., Jin J., Fang Z., Yang Y., Zha X. Increase in β1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin β1 stability in human hepatocellular carcinoma cell line SMMC-7721. J. Cell. Biochem. 2007, 100:230-241.
100. Zhao Y., Li J., Xing Y., Wang J., Lu C., Xin X., Geng M. N-acetylglucosaminyltransferase V mediates cell migration and invasion of mouse mammary tumor cells 4TO7 via RhoA and Rac1 signaling pathway. Mol. Cell Biochem. 2008, 309:199-208.
101. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., Nabi I.R., Wrana J.L., Dennis J.W. Regulation of cytokine receptors by Golgi N-glycans processing and endocytosis. Science 2004, 306:120-124.
102. 1 changes with melanoma progression. Biochim. Biophys. Acta 2003, 1643:113-123.
103. Gu J., Taniguchi N. Regulation of integrin functions by N-glycans. Glycoconj. J. 2004, 21:9-15.
104. 3 integrin N-oligosaccharides in metastatic melanoma WM9 and WM239 cell lines. Biochim. Biophys. Acta 2008, 1780:1421-1431.
105. 1 integrin. Endocrinology 2009, 150:990-999.
106. Lagana A., Goetz J.G., Cheung P., Raz A., Dennis J.W., Nabi I.R. Galectin binding to Mgat5- modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol. Cell. Biol. 2006, 26:3181-3193.
107. 1 integrin in determining the supramolecular organization of laminin-5 in the extracellular matrix of keratinocytes. Exp. Cell Res. 2003, 283:67-79.
108. 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 2000, 87:336-342.
109. Serini G., Valdembri D., Bussolino F. Integrins and angiogenesis: a sticky business. Exp. Cell Res. 2006, 312:651-658.
110. 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis 2002, 19:427-436.
111. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 2003, 20:203-213.
112. Liu Y., Pan D., Bellis S.L., Song Y. Effect of altered glycosylation on the structure of the I-like domain of β1 integrin: a molecular dynamics study. Proteins 2008, 73:989-1000.
113. 1 subunits and concomitant loss of fibronectin binding activity. J. Biol. Chem. 1994, 269:12325-12331.
114. Akiyama S.K., Yamada S.S., Yamada K.M. Analysis of the role of glycosylation of the human fibronectin receptor. J. Biol. Chem. 1989, 264:18011-18018.
115. Zhang Y., Zhao J., Zhang X., Guo H., Liu F., Chen H. Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions. Mol. Cell. Biochem. 2004, 260:137-146.
116. Passaniti A., Hart G.W. Cell sialylation and tumor metastasis: metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J. Biol. Chem. 1988, 263:7591-7603.
117. 5 subunit and their involvement in cell adhesion to fibronectin. J. Biol. Chem. 2001, 276:33657-33664.
118. Demetriou M., Nabi I.R., Coppolino M., Dedher S., Dennis J.W. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 1995, 130:383-392.
119. 1 reduces ligand binding and down-regulates cell adhesion and cell migration. J. Biol. Chem. 2004, 279:19747-19754.
120. 1 integrin sialylation. J. Biol. Chem. 2005, 280:37610-37615.
121. Shaikh F.M., Seales E.C., Clem W.C., Hennessy K.M., Zhuo Y., Bellis S.L. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp. Cell Res. 2008, 314:2941-2950.
122. Hoffmeister K.M., Josefsson E.C., Issac N.A., Clause H., Hartwig J.H., Stossel T.P. Glycosylation restores survival of chilled blood platelets. Science 2003, 301:1531-1534.
123. M lectin domain mediates the phagocytosis of chilled platelets. J. Biol. Chem. 2005, 280:18025-18032.
124. Heller M., von der Ohe M., Kleene R., Mohajeri H., Schachner M. The immunoglobulin-superfamily molecule basigin is a binding protein for oligomannosidic carbohydrates: an anti-idiotypic approach. J. Neurochem. 2003, 84:557-565.
125. Streuli Ch.H., Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem. J. 2009, 418:491-506.
126. 1 via association with tetraspanin CD151. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1939-1944.
127. Liu L., He B., Liu W.M., Zhou D., Cox J.V., Zhang X.A. Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J. Biol. Chem. 2007, 282:31631-31642.
128. 1 integrin. Curr. Opin. Cell Biol. 2000, 12:548-553.
129. 4 integrins in tumor invasion. Clin. Exp. Metastasis 2002, 19:217-223.
130. 1 integrin. J. Membr. Biol. 2004, 200:115-132.
131. 1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J. Cell Sci. 1999, 112:2615-2629.
132. 1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development 2002, 129:2303-2315.
133. 1 integrin is involved in melanoma cell migration and invasion. Exp. Cell Res. 1995, 219:233-242.
134. 1 integrin-mediated cell migration. J. Biol. Chem. 2006, 281:32122-32130.
135. 1 integrin down-regulates its functions. J. Biol. Chem. 2006, 281:38343-38350.
136. Aumailley M., Roussel P. Laminins of the dermo-epidermal junction. Matrix Biol. 1999, 18:19-28.
137. Giannelli G., Antonaci S. Biological and clinical relevance of Laminin-5 in cancer. Clin. Exp. Metastasis 2000, 18:439-443.
138. Tsuruta D., Kobayashi H., Imanishi H., Sugawara K., Ishii M., Jones J.C.R. Laminin-332-integrin interaction: a target for cancer therapy?. Curr. Med. Chem. 2008, 15:1968-1975.
139. 1 integrin-dependent secretion of MMP-9/gelatinase B. J. Cell Sci. 2000, 113:2909-2921.
140. Larjava H., Salo T., Haapasalmi K., Kramer R.H., Heino J. Expression of integrins and basement membrane components by wound keratinocyes. J. Clin. Invest. 1993, 92:1425-1435.
141. Decline F., Okamoto O., Mallein-Gerin F., Helbert B., Bernaud J., Rigal D., Rousselle P. Keratinocyte motility induced by TGF-β1 is accompanied by dramatic changes in cellular interactions with lamin 5. Cell Motil. Cytoskeleton 2003, 54:64-80.
142. 1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J. Cell Sci. 2004, 117:3947-3959.
143. 1 integrin: purification, regulation, and specific binding to laminin-5 and invasion in a mutually exclusive manner. Biochemistry 1998, 37:10945-10955.
144. 1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes. J. Cell Biochem. 1999, 72:189-209.
145. 1 integrin from human uterer epithelium (HCV29) cell line. Acta Biochim. Pol. 2002, 49:491-500.
146. Lityńska A., Przybył M., Pocheć E., Laidler P. Adhesion properties of human bladder cell lines with extracellular matrix components: the role of integrins and glycosylation. Acta Biochim. Pol. 2002, 49:643-650.
147. Lityńska A., Przybyło M., Pocheć E., Kremser E., Hoja-Łukowicz D., Sulowska U. Does glycosylation of melanoma cells influence their interactions with fibronectin?. Biochimie 2006, 88:527-534.
148. Ahmad S.A., Jung Y.D., Liu W., Reinmuth N., Parikh A., Stoeltzing O., Fan F., Ellis L.M. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis. Cancer Biol. 2002, 12:105-112.
149. Haass N.K., Smalley K.S.M., Li L., Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 2005, 18:150-159.
150. Neto D.S., Pantaleão L., Soares de Sá B.C., Landman G. Alpha-v-beta3 integrin expression in melanocytic nevi and cutaneous melanoma. J. Cutan. Pathol. 2007, 34:851-856.
151. Bafetti L.M., Young T.N., Itoh Y., Sharon M. Stack intact vitronectin induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem. 1998, 273:143-149.
152. v subunit by Membrane Type 1 Matrix Metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of Focal Adhesion Kinase. J. Biol. Chem. 2002, 277:9749-9756.
153. v subunit in tumor cells by Membrane Type-1 Matrix Metalloproteinase. J. Biol. Chem. 2002, 277:7377-7385.
154. Seiffert D., Smith J.W. The cell adhesion domain in plasma vitronecitn is cryptic. J. Biol. Chem. 1997, 272:13705-13710.
155. Podor T.J., Campbell S., Chindemi P., Foulon D.M., Farrell D.H., Walton P.D., Weitz J.I., Peterson C.B. Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gammaA/gamma' fibrinogen. J. Biol. Chem. 2002, 277:7520-7528.
156. Stefansson S., Su E.J., Ishigami S., Cale J.M., Gao Y., Gorlatova N., Lawrence D.A. The contributions of integrin affinity and integrin-cytoskeletal engagement in endothelial and smooth muscle cell adhesion to vitronectin. J. Biol. Chem. 2007, 282:15679-15689.
157. Baroni A., Paoletti I., Silvestri I., Buommin E., Carriero M.V. Cutaneous biology: early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis. Br. J. Dermatol. 2003, 148:424-433.